Sp. Matusiewicz et al., Hypersensitivity pneumonitis associated with co-proxamol (paracetamol plusdextropropoxyphene) therapy, POSTG MED J, 75(886), 1999, pp. 475-476
A 61-year-old man developed hypersensitivity pneumonitis and skin rash in c
lose association with taking co-proxamol. These problems occurred in spite
of being treated with prednisolone 40 mg daily (20 mg daily at the time of
presentation) for assumed cranial arteritis. A therapeutic challenge with p
aracetamol was negative and the patient continues to take this drug. It see
ms likely that this patient's rash and hypersensitivity pneumonitis was cau
sed by dextropropoxyphene. Dextropropoxyphene has not been reported previou
sly as a cause of hypersensitivity pneumonitis.